Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
SEPN
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -18.5%
SEPN
Septerna, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
septerna
phase
drug
healthcare
conference
clinical
gpcr
diseases
development
announced
results
annual
stage
biotechnology
discovery
2025
analysts
double
announces
positive